Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00491
|
|||||
| Drug Name |
Bezafibrate
|
|||||
| Synonyms |
2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid; 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid; 2-[4-(2-[4-Chlorobenzamido]ethyl)-phenoxy]-2-methylpropanoic acid; 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid; 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]isobutyric Acid; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid; A-[4-(4-chlorobenzoylaminoethyl)phenoxy]isobutyric acid; Azufibrat; Azupharma Brand of Bezafibrate; BF-759; BM 15.075; BM 15075; BM-15.075; BM-15075; BM15.075; Bayer Brand of Bezafibrate; Befibrat; Befizal; Berlin Chemie Brand of Bezafibrate; Berlin-Chemie Brand of Bezafibrate; Betapharm Brand of Bezafibrate; Beza Lande; Beza Puren; Beza-Lande; Beza-Puren; BezaLande; BezaPuren; Bezabeta; Bezacur; Bezafibrat; Bezafibrat PB; Bezafibrate (JP15/USAN/INN); Bezafibrate Azupharma Brand; Bezafibrate Bayer Brand; Bezafibrate Berlin-Chemie Brand; Bezafibrate Betapharm Brand; Bezafibrate Cryopharma Brand; Bezafibrate Elfar Brand; Bezafibrate Hennig Brand; Bezafibrate Hexal Brand; Bezafibrate Isis Brand; Bezafibrate Lakeside Brand; Bezafibrate Merckle Brand; Bezafibrate Roche Brand; Bezafibrate Synthelabo Brand; Bezafibrate TAD Brand; Bezafibrate Teva Brand; Bezafibrate [USAN:BAN:INN:JAN]; Bezafibrato; Bezafibrato [INN-Spanish]; Bezafibrato [Spanish]; Bezafibratum; Bezafibratum [INN-Latin]; Bezafisal;Bezalip; Bezalip (TN); Bezalip Retard; Bezamerck; Bezatol; Bezatol SR; Bezatol SR (TN); Boehringer Mannheim Brand of Bezafibrate; Cedur; Cryopharma Brand of Bezafibrate; Difaterol; Durabezur; Elfar Brand of Bezafibrate;Hennig Brand of Bezafibrate; Eulitop; Hexal Brand of Bezafibrate; Isis Brand of Bezafibrate; LO 44; Lakeside Brand of Bezafibrate; Lipox; Merckle Brand of Bezafibrate; PB, Bezafibrat; Reducterol; Regadrin B; Roche Brand of Bezafibrate; Sklerofibrat; Solibay; Synthelabo Brand of Bezafibrate; TAD Brand of Bezafibrate; Teva Brand of Bezafibrate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antilipemic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H20ClNO4
|
|||||
| Canonical SMILES |
CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
|
|||||
| InChI |
InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)
|
|||||
| InChIKey |
IIBYAHWJQTYFKB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 41859-67-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 361.8 | Topological Polar Surface Area | 75.6 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321679
, 11112764
, 11121379
, 11121859
, 11335267
, 11360506
, 11362448
, 11364337
, 11365010
, 11366899
, 11367572
, 11369461
, 11370167
, 11370168
, 11372718
, 11373173
, 11373808
, 11375734
, 11377623
, 11461478
, 11466406
, 11467526
, 11484560
, 11486192
, 11488738
, 11491315
, 11492140
, 11495257
, 12015374
, 14926008
, 24891983
, 26612282
, 26680411
, 26747025
, 26747026
, 26751545
, 26751546
, 26751547
, 29214784
, 3221863
, 34704995
, 46509188
, 4720908
, 47217032
, 47291353
, 7848429
, 7978783
, 8149814
, 8175852
, 855877
|
|||||
| ChEBI ID |
ChEBI:47612
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.